Informace o publikaci

Cloning, expression and purification of the human Islet Amyloid Polypeptide (hIAPP) from Escherichia coli


CAMARGO Diana C. Rodrigues TRIPSIANES Konstantinos KAPP Tobias G. MENDES Joaquim SCHUBERT Jasmin CORDES Burghard REIF Bernd

Rok publikování 2015
Druh Článek v odborném periodiku
Časopis / Zdroj Protein Expression and Purification
Fakulta / Pracoviště MU

Středoevropský technologický institut

Obor Genetika a molekulární biologie
Klíčová slova Amyloid; Diabetes; Recombinant protein; human Islet Amyloid Polypeptide (hIAPP); Escherichia coli; Nuclear magnetic resonance (NMR)
Popis Type II diabetes is characterized by deposition of the hormone human Islet Amyloid Polypeptide (hIAPP). Formation of hIAPP amyloid fibrils and aggregates is considered to be responsible for pancreatic beta-cell losses. Therefore, insight into the structure of hIAPP in the solid-state and in solution is of fundamental importance in order to better understand the action of small molecules, which can potentially dissolve protein aggregates and modulate cell toxicity. So far, no procedure has been described that allows to obtain the native human IAPP peptide at high yields. We present here a cloning, expression and purification protocol that permits the production of 2.5 and 3 mg of native peptide per liter of minimal and LB medium, respectively. In the construct, hIAPP is fused to a chitin binding domain (CBD). The CBD is subsequently cleaved off making use of intein splicing reaction which yield amidation of the C-terminus. The N-terminus contains a solubilization domain which is cleaved by V8 protease, avoiding additional residues at the N-terminus. The correct formation of the disulfide bond is achieved by oxidation with H2O2. (C) 2014 Elsevier Inc. All rights reserved.

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info